[I-123]beta-CIT and SPECT in essential tremor and Parkinson's disease

Citation
S. Asenbaum et al., [I-123]beta-CIT and SPECT in essential tremor and Parkinson's disease, J NEURAL TR, 105(10-12), 1998, pp. 1213-1228
Citations number
57
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEURAL TRANSMISSION
ISSN journal
03009564 → ACNP
Volume
105
Issue
10-12
Year of publication
1998
Pages
1213 - 1228
Database
ISI
SICI code
0300-9564(1998)105:10-12<1213:[ASIET>2.0.ZU;2-L
Abstract
Resting and postural tremor may occur in essential tremor (ET) and Parkinso n's disease (PD). The aim of the present study was to investigate the cocai ne derivative [I-123]beta-CIT, which labels striatal dopamine transporters, and SPECT in differentiating these diseases. Methods: 30 healthy volunteers, 32 patients with ET and 29 patients with id iopathic PD of Hoehn/Yahr stage I were investigated. Specific over nondispl aceable binding ratios (target/cerebellum-1) were calculated for the striat um. the caudate nucleus and the putamen separately as well as a ratio putam en/caudate and the percent deviation of each patient's ratio from age-expec ted control values. Results: Striatal [I-123]beta-CIT binding ratios in ET were within normal r anges and showed only a discrete elevation to age-expected control values ( +14.6%). In PD significantly reduced specific binding was evident not only contralaterally to the clinically affected side (putamen: -62%, caudate nuc leus: -35%), but also ipsilaterally (putamen: -45%, caudate nucleus: -22%). All investigated parameters differed significantly between PD and controls and ET respectively. Conclusion: Imaging striatal dopamine transporters with [I-123]beta-CIT and SPECT could clearly distinguish between ET and PD in an early stage of the disease. Findings do not suggest a subclinical involvement of dopaminergic nigrostriatal neurons in ET.